Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
 
  
   
Insider Information:   Baker Felix
Relationship:   Director, 10% Owner
City:  
State:  
   
Insider Summary:
  
   
Companies Owned :   20    
Direct Shares   927,207    

Indirect Shares

  141,861,898      
Direct Value   $81,660,525    

Indirect Value

  $12,932,114,466      
Total Shares   142,789,105      
Total Value   $13,013,774,992      


Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634 Incyte Corp
 $32,141,876 Seagen Inc
 $49,182,531 Synageva BioPharma Corp
 $0 Genomic Health Inc
 $18,271 Biocryst Pharmaceuticals Inc
 $301,214 Neurogene
 $16,634
 


Historical Performance :
Based on 6 Month Return Percentages
Buys 
Sells 

     Total Filings :

    36   
    6    

     Stock price went up :

    15   
    6    
     Stock price went down :
    21   
    0    
   
     Gain/Loss Ratio :
   0.0   
   6.0   
     Percentage Gain/Loss :
   -24.3%
 18.0%
     
   
Holdings :
     Menu Company Name Ticker Relation Direct Date Direct Shares Indirect Date Indirect Shares Total Value Sold  
            Incyte Corp INCY Director, 10% Owner 2023-09-29 559,963 2023-09-29 33,480,292    Premium*  
            Ardea Biosciences Inc RDEA Director, 10% Owner 2003-10-06 0 2012-02-01 116,454    Premium*  
            Seagen Inc SGEN Director, 10% Owner 2018-02-01 215,015 2018-02-01 44,355,335    Premium*  
            Synageva BioPharma Corp GEVA Director, 10% Owner 2015-06-22 100,503 2015-06-22 9,328,233    Premium*  
            Viropharma Inc VPHM 10% Owner 2005-01-31 0 2011-12-14 303,264    Premium*  
            Aceragen, Inc ACGN Director 0 2017-07-03 145,453    Premium*  
            Tapestry Pharmaceuticals Inc TPPHQ 10% Owner 0 2008-10-15 0    Premium*  
            Genomic Health Inc GHDX Director, 10% Owner 2012-10-01 288 2012-10-01 11,377,485    Premium*  
            Allos Therapeutics Inc ALTH 10% Owner 0 2009-02-06 1,629    Premium*  
            Biocryst Pharmaceuticals Inc BCRX 10% Owner 2016-08-16 46,918 2016-08-16 9,418,390    Premium*  
            Heron Therapeutics Inc HRTX 10% Owner 0 2011-06-30 5,266,568    Premium*  
            Adolor Corp ADLR 10% Owner 2010-04-26 0 2011-12-19 0    Premium*  
            Diadexus Inc DDXS 10% Owner 0 2010-07-28 140,525    Premium*  
            Pharmacyclics Inc PCYC 10% Owner 0 2011-08-22 1,809    Premium*  
            Ocera Therapeutics Inc OCRX 10% Owner 2012-03-12 0 2012-03-14 57,704    Premium*  
            XOMA Corporation XOMA Director, 10% Owner 2012-10-29 0 2012-10-29 480,639    Premium*  
            Neurogene NGNE 10% Owner 2015-08-07 4,520 0    Premium*  
            Invitae Corp NVTA 10% Owner 0 2015-08-27 6,554,967    Premium*  
            Bellicum Pharmaceuticals, Inc BLCM 10% Owner 0 2015-12-24 4,865,647    Premium*  
            Kodiak Sciences Inc. KOD Director, 10% Owner 2022-01-21 0 2022-06-06 15,967,504    Premium*  
* Premium Members only  

Records found :    1397         Free Registration Required For Full Results.    Limit: 25

Download
  Page 29 of 56
Ticker Company Name Relation   Off-Dir-10% Trans. Date Form Action Price Mkt Value D/I Shares    Holdings   
Rank

 
3m +/-  
Form
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $410,220 I/I 32,630 1,215,554 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $51,658 I/I 4,109 282,109 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-10 4 B $12.55 $82,673 I/I 6,576 323,576 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-13 4 B $13.56 $28,474 I/I 2,100 284,209 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-13 4 B $13.56 $242,152 I/I 17,859 1,708,989 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-13 4 B $13.56 $45,572 I/I 3,361 326,937 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-13 4 B $13.56 $226,166 I/I 16,680 1,232,234 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-14 4 B $13.32 $297,329 I/I 22,322 1,731,311 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-14 4 B $13.32 $34,978 I/I 2,626 286,835 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-14 4 B $13.32 $277,722 I/I 20,850 1,253,084 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-09-14 4 B $13.32 $55,971 I/I 4,202 331,139 2.25 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-10-13 4 D $0.00 $0 I/I (586,556) 1,144,755 -
SGEN Seagen Inc Director   –       •       •   2004-10-13 4 D $0.00 $0 I/I (13,542) 94,049 -
SGEN Seagen Inc Director   –       •       •   2004-10-13 3 IO $0.00 $0 I/I 0 13,542 -
GEVA Synageva BioPharma Corp Director   –       •       •   2004-10-13 3 IO $0.00 $0 I/I 0 502,454 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 4 B $4.88 $55,581 I/I 11,058 24,600 2.25 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 3 IO $0.00 $0 I/I 0 13,552 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 3 IO $0.00 $0 I/I 0 70,599 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 3 IO $0.00 $0 I/I 0 5,877 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 4 B $4.88 $41,698 I/I 8,296 8,296 2.25 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 4 B $4.88 $86,533 I/I 17,216 37,874 2.25 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 4 B $4.88 $444,365 I/I 88,408 190,325 2.25 -
SGEN Seagen Inc Director   –       •       •   2005-03-22 4 B $4.88 $399,094 I/I 79,401 173,450 2.25 -
SGEN Seagen Inc Director   –       •       •   2005-03-23 4/A B $4.96 $26,156 I/I 5,274 11,155 2.25 -
SGEN Seagen Inc Director   –       •       •   2005-03-23 4 B $4.96 $314,315 I/I 63,376 133,975 2.25 -

  1397  Records found
  1   2   3   4   5   6   7   8   9   10   11   12   13   14   15   16   17   18   19   20   21   22   23   24   25   26   27   28   29  30   31   32   33   34   35   36   37   38   39   40   41   42   43   44   45   46   47   48   49   50   51   52   53   54   55   56      
  Page 29 of 56  
 
Free Registration Required For Full Results.    Limit: 25

 
 
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
OE - Options Exercised A - Aquired
  IO - Initital Ownership D - Disposed